Company Filing History:
Years Active: 2011-2015
Title: Weimin Zhao: Innovator in Healthcare and Pharmaceuticals
Introduction
Weimin Zhao is a prominent inventor based in Shanghai, China. He has made significant contributions to the fields of healthcare products, food additives, and pharmaceuticals. With a focus on innovative solutions for appetite control and treatment of various diseases, Zhao has secured a total of 2 patents.
Latest Patents
Zhao's latest patents include the use of 3,8,12,14,17,20-oxo-substituted pregnene glycosides in the preparation of healthcare products, food additives, and pharmaceuticals for the inhibition of appetite. This invention relates to the use of these glycosides in creating products aimed at losing body weight and controlling appetite in humans and animals. The formula involves a saccharide group and an acyl group. Another notable patent is for ester prodrugs of prostratin and related phorbol compounds. This invention focuses on the treatment of viral infections, neoplastic diseases, and inflammatory reactions, utilizing phorbol compounds derivatized with specific groups linked to the phorbol residue.
Career Highlights
Throughout his career, Weimin Zhao has worked with notable organizations such as Salvia Sciences, Inc. and the Chinese Academy of Sciences. His work has been instrumental in advancing research and development in his areas of expertise.
Collaborations
Zhao has collaborated with esteemed colleagues, including Rensheng Xu and Chun Jiang, contributing to various innovative projects and research initiatives.
Conclusion
Weimin Zhao's contributions to healthcare and pharmaceuticals through his patents reflect his dedication to innovation and improving human health. His work continues to influence the industry and inspire future advancements.